| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |